The joint association of glycated haemoglobin and low-density lipoprotein cholesterol with type 2 diabetic neuropathy

Neuropathy is highly prevalent and has a poor prognosis in type 2 diabetes mellitus (T2DM) patients. T2DM is accompanied by abnormal glucose and lipid metabolism. Glycated haemoglobin (HbA1c) is a risk factor with a limited regulatory role. The role of low-density lipoprotein cholesterol (LDL-C) also remains unclear. Here, we analysed the effects of HbA1c and LDL-C on type 2 diabetic neuropathy. Patients with T2DM with no baseline neuropathy were selected from the UK Biobank (UKB) database; 1,484 patients were enrolled based on a 12-year follow-up period. Patients were grouped according to their HbA1c levels(< 7%, 7–9%, and ≥ 9%) and their LDL-C levels (< 2.6 mmol/L and ≥ 2.6 mmol/L). Cox regression analysis revealed associations between HbA1c and LDL-C levels and the risk of type 2 diabetic neuropathy. Next, logistic regression was performed using clinical data from 611 patients with T2DM. We also analysed the interaction between LDL-C and HbA1c. After adjustment for confounding factors, compared with HbA1c < 7%, both HbA1c 7–9% and ≥ 9% were associated with an increased risk of type 2 diabetic neuropathy [HR = 1.62 (1.31–2.01); P < 0.001; HR = 2.44 (1.76–3.38); P < 0.001] in the UKB; compared with LDL-C < 2.6 mmol/L, LDL-C ≥ 2.6 mmol/L did not increase the risk of type 2 diabetic neuropathy [HR = 1.06(0.81–1.40); P = 0.675]. Compared with LDL-C ≥ 2.6 mmol/L combined with HbA1c < 7%, LDL-C ≥ 2.6 mmol/L combined with HbA1c ≥ 9% increased the risk of type 2 diabetic neuropathy [HR = 2.80 (1.76–4.48); P < 0.001]. Consistent findings were observed in the logistic regression analysis of clinical data and in sex-stratified analyses. HbA1c is an independent risk factor for neuropathy in patients with T2DM. LDL-C is not associated with type 2 diabetic neuropathy. However, in the context of suboptimal LDL-C control, extremely poor HbA1c control is closely associated with diabetic neuropathy than well controlled HbA1c.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-15
DOI
https://doi.org/10.1038/s41598-026-80710-y
Primary Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The joint association of glycated haemoglobin and low-density lipoprotein cholesterol with type 2 diabetic neuropathy

LiLan Wang, Zixuan Ru, Tianshu Han, Kerou Li et al.
Scientific Reports
Diabetes, Cardiovascular Risks, and Lipoproteins
article

The joint association of glycated haemoglobin and low-density lipoprotein cholesterol with type 2 diabetic neuropathy

LiLan Wang, Zixuan Ru, Tianshu Han, Kerou Li, 张晓娜, Hong Qiao, Na Lv, Nana Liang, Shengnan Gao, Minnan Wang
article en

Abstract

Neuropathy is highly prevalent and has a poor prognosis in type 2 diabetes mellitus (T2DM) patients. T2DM is accompanied by abnormal glucose and lipid metabolism. Glycated haemoglobin (HbA1c) is a risk factor with a limited regulatory role. The role of low-density lipoprotein cholesterol (LDL-C) also remains unclear. Here, we analysed the effects of HbA1c and LDL-C on type 2 diabetic neuropathy. Patients with T2DM with no baseline neuropathy were selected from the UK Biobank (UKB) database; 1,484 patients were enrolled based on a 12-year follow-up period. Patients were grouped according to their HbA1c levels(< 7%, 7–9%, and ≥ 9%) and their LDL-C levels (< 2.6 mmol/L and ≥ 2.6 mmol/L). Cox regression analysis revealed associations between HbA1c and LDL-C levels and the risk of type 2 diabetic neuropathy. Next, logistic regression was performed using clinical data from 611 patients with T2DM. We also analysed the interaction between LDL-C and HbA1c. After adjustment for confounding factors, compared with HbA1c < 7%, both HbA1c 7–9% and ≥ 9% were associated with an increased risk of type 2 diabetic neuropathy [HR = 1.62 (1.31–2.01); P < 0.001; HR = 2.44 (1.76–3.38); P < 0.001] in the UKB; compared with LDL-C < 2.6 mmol/L, LDL-C ≥ 2.6 mmol/L did not increase the risk of type 2 diabetic neuropathy [HR = 1.06(0.81–1.40); P = 0.675]. Compared with LDL-C ≥ 2.6 mmol/L combined with HbA1c < 7%, LDL-C ≥ 2.6 mmol/L combined with HbA1c ≥ 9% increased the risk of type 2 diabetic neuropathy [HR = 2.80 (1.76–4.48); P < 0.001]. Consistent findings were observed in the logistic regression analysis of clinical data and in sex-stratified analyses. HbA1c is an independent risk factor for neuropathy in patients with T2DM. LDL-C is not associated with type 2 diabetic neuropathy. However, in the context of suboptimal LDL-C control, extremely poor HbA1c control is closely associated with diabetic neuropathy than well controlled HbA1c.

Scientific Reports
Harbin Medical University (CN), Second Affiliated Hospital of Harbin Medical University (CN), Heilongjiang Academy of Medical Sciences (CN)
Diabetes, Cardiovascular Risks, and Lipoproteins
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon